These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 26884857
1. Effect of halofuginone on the inhibition of proliferation and invasion of hepatocellular carcinoma HepG2 cell line. Huo S, Yu H, Li C, Zhang J, Liu T. Int J Clin Exp Pathol; 2015; 8(12):15863-70. PubMed ID: 26884857 [Abstract] [Full Text] [Related]
2. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP. Liu H, Chen F, Zhang L, Zhou Q, Gui S, Wang Y. Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208 [Abstract] [Full Text] [Related]
3. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell. Liu Z, Li G, Gou Y, Xiao D, Luo G, Saavedra JE, Liu J, Wang H. Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880 [Abstract] [Full Text] [Related]
4. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling. Ke X, Zhao Y, Lu X, Wang Z, Liu Y, Ren M, Lu G, Zhang D, Sun Z, Xu Z, Song JH, Cheng Y, Meltzer SJ, He S. Oncotarget; 2015 Oct 20; 6(32):32610-21. PubMed ID: 26416455 [Abstract] [Full Text] [Related]
5. Annonaceous acetogenins reverses drug resistance of human hepatocellular carcinoma BEL-7402/5-FU and HepG2/ADM cell lines. Qian JQ, Sun P, Pan ZY, Fang ZZ. Int J Clin Exp Pathol; 2015 Oct 20; 8(9):11934-44. PubMed ID: 26617951 [Abstract] [Full Text] [Related]
6. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway. Gao C, Li X, Yu S, Liang L. J BUON; 2019 Oct 20; 24(5):1964-1969. PubMed ID: 31786862 [Abstract] [Full Text] [Related]
7. Identification of MicroRNAs Involved in Growth Arrest and Apoptosis in Hydrogen Peroxide-Treated Human Hepatocellular Carcinoma Cell Line HepG2. Luo Y, Wen X, Wang L, Gao J, Wang Z, Zhang C, Zhang P, Lu C, Duan L, Tian Y. Oxid Med Cell Longev; 2016 Oct 20; 2016():7530853. PubMed ID: 27597883 [Abstract] [Full Text] [Related]
8. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis. Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C. Carcinogenesis; 2013 Jun 20; 34(6):1323-30. PubMed ID: 23404993 [Abstract] [Full Text] [Related]
9. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein. Liu XY, Liu SP, Jiang J, Zhang X, Zhang T. Eur Rev Med Pharmacol Sci; 2016 Jun 20; 20(6):1098-108. PubMed ID: 27049263 [Abstract] [Full Text] [Related]
10. Glutamate release inhibitor, Riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production. Seol HS, Lee SE, Song JS, Lee HY, Park S, Kim I, Singh SR, Chang S, Jang SJ. Cancer Lett; 2016 Nov 28; 382(2):157-165. PubMed ID: 27612558 [Abstract] [Full Text] [Related]
11. Evaluation of the effects of the water-soluble total flavonoids from Isodon lophanthoides var.gerardianus (Benth.) H. Hara on apoptosis in HepG2 cell: Investigation of the most relevant mechanisms. Feng CP, Tang HM, Huang S, Hou SZ, Liang J, Huang W, Lai XP. J Ethnopharmacol; 2016 Jul 21; 188():70-9. PubMed ID: 27132715 [Abstract] [Full Text] [Related]
12. Quercetin-3-O-glucoside induces human DNA topoisomerase II inhibition, cell cycle arrest and apoptosis in hepatocellular carcinoma cells. Sudan S, Rupasinghe HP. Anticancer Res; 2014 Apr 21; 34(4):1691-9. PubMed ID: 24692698 [Abstract] [Full Text] [Related]
16. Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo. Huang NC, Huang RL, Huang XF, Chang KF, Lee CJ, Hsiao CY, Lee SC, Tsai NM. Biosci Rep; 2021 Jul 30; 41(7):. PubMed ID: 34151367 [Abstract] [Full Text] [Related]
17. Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G2/M cell cycle arrest and apoptosis. Zhang DM, Liu JS, Tang MK, Yiu A, Cao HH, Jiang L, Chan JY, Tian HY, Fung KP, Ye WC. Eur J Pharmacol; 2012 Oct 05; 692(1-3):19-28. PubMed ID: 22841670 [Abstract] [Full Text] [Related]
18. Research on anti-hepatocellular carcinoma activity and mechanism of Polygala fallax Hemsl. Yao Z, Li Y, Wang Z, Lan Y, Zeng T, Gong H, Zhu K, Tang H, Gu S. J Ethnopharmacol; 2020 Oct 05; 260():113062. PubMed ID: 32512042 [Abstract] [Full Text] [Related]
19. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Dai QS, Liu W, Wang XB, Lu N, Gong DD, Kong LY, Guo QL. Anticancer Drugs; 2011 Jan 05; 22(1):46-57. PubMed ID: 20948430 [Abstract] [Full Text] [Related]
20. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling. Ding J, Wen W, Xiang D, Yin P, Liu Y, Liu C, He G, Cheng Z, Yin J, Sheng C, Zhang W, Nan F, Ye W, Zhang X, Wang H. Oncotarget; 2015 May 10; 6(13):11627-39. PubMed ID: 25890498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]